Then, we set up a nomogram model on the basis of the five candidate cuproptosis modulators (ATP7B, DLAT, MTF1, PDHB, GCSH), which has been evaluated via the DCA curve to produce benefit to IDD patients in virtue of decisions on the basis of the nomogram model. This evidence concerns the gene GCSH and intervertebral disk degenerative disorder.